Filing Details

Accession Number:
0001209191-18-002982
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-09 17:33:42
Reporting Period:
2018-01-05
Accepted Time:
2018-01-09 17:33:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1643921 N. Sangeeta Bhatia C/O Vertex Pharmaceuticals Incorporated
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-05 10,753 $126.68 14,706 No 4 M Direct
Common Stock Disposition 2018-01-05 10,753 $156.00 3,953 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-01-05 10,753 $0.00 10,753 $126.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,247 2025-06-03 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Dr. Bhatia's company-approved trading plan under Rule 10b5-1.
  2. The option vests in 16 quarterly installments from 06/04/2015.